Tao Jin

Title: Innovations of Tao Jin in T Cell Engineering

Introduction

Tao Jin is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology, particularly in T cell engineering. His innovative work focuses on enhancing the effectiveness of immune cells in targeting tumors.

Latest Patents

Tao Jin holds a patent for "Compositions and methods for T cell engineering." This patent describes an engineered immune cell that includes a CAR (Chimeric Antigen Receptor) or engineered TCR (T Cell Receptor). The engineered immune cells are designed to inhibit host immune cells, such as T cells and NK cells, while enhancing their own survival and persistence in vivo. This innovation aims to improve tumor-killing activity, making it a significant advancement in cancer treatment.

Career Highlights

Throughout his career, Tao Jin has worked with notable companies in the biotechnology sector. He has been associated with Gracell Biotechnologies (Shanghai) Co., Ltd. and Suzhou Gracell Biotechnologies Co., Ltd. His work in these organizations has contributed to the development of cutting-edge therapies in the field of immunotherapy.

Collaborations

Tao Jin has collaborated with several professionals in his field, including Xinxin Wang and Chunhui Yang. These collaborations have fostered a productive environment for innovation and research in T cell engineering.

Conclusion

Tao Jin's contributions to T cell engineering represent a significant advancement in cancer treatment. His innovative patent and collaborations highlight his commitment to improving therapeutic strategies in immunology. His work continues to inspire advancements in the field, paving the way for future innovations.